Different effects of two gold compounds on muscle contraction, membrane potential and ryanodine receptor

European Journal of Pharmacology

Volumn 374, Issue 3, 1999, Pages 477-487

  Oba, Toshiharu ^a   Ishikawa, Tatsuya ^a   Yamaguchi, Mamoru ^b  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Ca2+ release channel ryanodine receptor; Gold sodium thiomalate; Membrane potential; Muscle contraction; NaAuCl4; Thiomalic acid

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; GOLD CHLORIDE; GOLD DERIVATIVE; LYSOSOME ENZYME; RUTHENIUM RED; RYANODINE RECEPTOR; THIOMALIC ACID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FROG; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MUSCLE CONTRACTION; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; TOXICITY TESTING;

ACTION POTENTIALS; ANIMALS; ANTIRHEUMATIC AGENTS; CALCIUM; CHLORIDES; GOLD COMPOUNDS; GOLD SODIUM THIOMALATE; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCLE, SKELETAL; RABBITS; RANIDAE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; THIOMALATES;

EID: 0033045874     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00317-9     Document Type: Article

References (28)

1. 2+ release channel. J. Biol. Chem. 272:1997;3739-3748.
2. 2 and dithiothreitol. Am. J. Physiol. 267:1994;H1010-H1016. Heart Circ. Physiol, 36.
3. Campbell J.M., Reglinski J., Smith W.E., Porter D., Sturrock R.D. Action of sodium aurothiomalate on erythrocyte membrane. Ann. Rheuma. Dis. 51:1992;969-971.
4. Chaffman M., Brogden R.N., Heel R.C., Speight T.M., Avery G.S. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis. Drugs. 27:1984;378-424.
5. Chang C.C., Lu S.E., Wang P.N., Chuang S.T. A comparison of the effects of various sulfhydryl reagents and chlorpromazine. Eur. J. Pharmacol. 11:1970;195-203.
6. Danpure C.J., Fyfe D.A., Gumpel J.M. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro. Ann. Rheuma. Dis. 38:1979;364-370.
7. Dempster, J., 1993. Computer analysis of electrophysiological signals. Academic Press, Hartcourt Brace Jovanovich Pub., London.
8. 2+ release channels from sheep myocardium. Am. J. Physiol. 272:1997;C1908-C1918. Cell Physiol, 41.
9. 2+ release channel from skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 270:1995;25557-25563.
10. Griem P., Takahashi K., Kalbacher H., Gleichmann E. The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues. J. Immunol. 155:1995;1575-1587.
11. Hirohata S. Inhibition of human B cell activation by gold compounds. Clin. Immun. Immunopath. 81:1996;175-181.
12. Juang M.S. An electrophysiological study of the action of methylmercuric chloride and mercuric chloride on the sciatic nerve-sartorius muscle preparation of the frog. Toxicol. Appl. Pharmacol. 37:1976;339-348.
13. Klinkhoff A.V., Teufel A. Reinstitution of gold after gold induced proteinuria. J. Rheumatol. 24:1997;1277-1279.
14. Koh W.H., Boey M.L. Polyneuropathy following intra-muscular sodium aurothiomalate for rheumatoid arthritis - a case report. Ann. Acad. Med. Singapore. 21:1992;821-822.
15. Koshita M., Oba T. Caffeine treatment inhibits drug-induced calcium release from sarcoplasmic reticulum and caffeine contracture but not tetanus in frog skeletal muscle. Can. J. Physiol. Pharmacol. 67:1989;890-895.
16. Lehtinen K., Isomaki H. Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. J. Rheumatol. 18:1991;524-529.
17. Lipsky P.E., Ziff M. Inhibition of antigen- and mitogen-induced lymphocyte proliferation by gold compounds. J. Clin. Invest. 59:1977;455-466.
18. 2+ causes neurotoxicity at an intracellular site following entry through Na and Ca channels. Brain Res. 267:1983;375-379.
19. Munro R., Hampson R., McEntegart A., Thomson E.A., Madhok R., Capell H. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann. Rheum. Dis. 57:1998;88-93.
20. Nihonyanagi K., Oba T. Gold ion induces contraction in frog skeletal muscle fibers. Eur. J. Pharmacol. 238:1993;149-155.
21. Nihonyanagi K., Oba T. Gold ion inhibits silver ion induced contracture and activates ryanodine receptors in skeletal muscle. Eur. J. Pharmacol. 311:1996;271-276.
22. Oba T., Hotta K. Silver ion-induced tension development and membrane depolarization in frog skeletal muscle fibres. Pfluegers Arch. 405:1985;354-359.
23. Oba T., Baskin R.J., Lieber R.L. Light diffraction studies of active muscle fibres as a function of sarcomere length. J. Muscle Res. Cell Motil. 2:1981;215-224.
24. 2+-release channel in frog skeletal muscle. Am. J. Physiol. 271:1996;C810-C818. Cell Physiol, 40.
25. 2-induced channel activation are on luminal side of ryanodine receptors. Am. J. Physiol. 274:1998;C914-C921. Cell Physiol, 43.
26. Rudge S.R., Perrett D., Kelly M. Failure of oral thiomalate to act as an alternative to intramuscular gold in rheumatoid arthritis. Ann. Rheum. Dis. 47:1988;224-227.
27. Suzuki H., Baba S., Uchigasaki S., Murase M. Localized argyria with chrysiasis caused by implanted acupuncture needles. Distribution and chemical forms of silver and gold in cutaneous tissue by electron microscopy and X-ray microanalysis. J. Am. Acad. Dermatol. 29:1993;833-837.
28. Wong K., Parente J., Pradad K.V., Ng D. Auranofin modulated cytoplasmic free calcium in neutrophils by mobilizing intracellular calcium and inhibiting protein kinase. J. Biol. Chem. 265:1990;21454-21461.